NCT07332533 2026-01-12A Study of KN026-based Combination Therapy in HER2-positive Gastric CancerShanghai JMT-Bio Inc.Phase 2/3 Not yet recruiting490 enrolled
NCT04290793 2026-01-07Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast CancerHebei Medical University Fourth HospitalPhase 2/3 Active not recruiting113 enrolled
NCT05980481 2025-09-29A Study of RC48-ADC Combination Therapies as First-line Treatment in Advanced Metastatic Gastric CancerRemeGen Co., Ltd.Phase 2/3 Active not recruiting201 enrolled